Literature DB >> 26801503

MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1.

Ying-Jie Li1, Chen Ping1, Jian Tang1, Wen Zhang1.   

Abstract

MicroRNA-455 (miRNA-455), which is downregulated in human cancer, potently mediates the multiple steps of carcinogenesis. However, the role of miR-455 in non-small cell lung cancer (NSCLC) carcinogenesis remains unclear. In present study, we determined the mature miRNA-455 expression in NSCLC tissues and cells by real-time PCR. Follow-up studies examined the effects of a miR-455 mimic (gain of function) on cell proliferation, migration, and invasion. Our data indicate that miR-455 was significantly down-regulated in NSCLC cell lines and tissues. In functional assays, overexpression of miR-455 suppressed the proliferation, migration, and invasion of NSCLC cell lines. Data from reporter assays showed that miR-455 directly binds to 3'UTR of ZEB1 and suppresses the endogenous level of ZEB1 protein expression. Furthermore, overexpression of ZEB1 reverses miR-455-suppressed malignant phenotype of NSCLC cells. Moreover, we found that upregulation of ZEB1 expression is inversely associated with miR-455 expression in NSCLC tissues. Taken together, miR-455 as an anti-oncogene in non-small cell lung cancer through up-regulation of ZEB1 and serve as a potential therapeutic target in NSCLC.
© 2016 International Federation for Cell Biology.

Entities:  

Keywords:  ZEB1; miR-455; migration; non-small cell lung cancer

Mesh:

Substances:

Year:  2016        PMID: 26801503     DOI: 10.1002/cbin.10584

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  26 in total

1.  MiR-101 inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1.

Authors:  Le Han; Wenjuan Chen; Yanmin Xia; Yangrong Song; Zheng Zhao; Hao Cheng; Tao Jiang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  Identification of miRNA biomarkers of pneumonia using RNA-sequencing and bioinformatics analysis.

Authors:  Sai Huang; Cong Feng; Yong-Zhi Zhai; Xuan Zhou; Bei Li; Li-Li Wang; Wei Chen; Fa-Qin Lv; Tan-Shi Li
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

3.  miR-455-5p regulates atrial fibrillation by targeting suppressor of cytokines signaling 3.

Authors:  Weiling Li; Na Qi; Shuo Wang; Wenyan Jiang; Tao Liu
Journal:  J Physiol Biochem       Date:  2021-04-01       Impact factor: 4.158

4.  MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.

Authors:  Junlei Han; Jianping Hu; Fang Sun; Hongzhi Bian; Bingxiang Tang; Xiang Fang
Journal:  Mol Cell Biochem       Date:  2020-10-30       Impact factor: 3.396

5.  miEAA: microRNA enrichment analysis and annotation.

Authors:  Christina Backes; Qurratulain T Khaleeq; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2016-04-29       Impact factor: 16.971

Review 6.  Circular RNAs and their participation in stemness of cancer.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Med Oncol       Date:  2020-04-07       Impact factor: 3.064

7.  A feedback loop consisting of RUNX2/LncRNA-PVT1/miR-455 is involved in the progression of colorectal cancer.

Authors:  Jie Chai; Dawei Guo; Wanli Ma; Dali Han; Wei Dong; Hongliang Guo; Yi Zhang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

8.  Mechanism of miR-455-3 in suppressing epithelial-mesenchymal transition and angiogenesis of non-small cell lung cancer cells.

Authors:  Chong Meng; Kai Liu; Xingjun Cai; Yongxing Chen
Journal:  Cell Stress Chaperones       Date:  2022-01-22       Impact factor: 3.827

9.  MicroRNA‑643 regulates the expression of ZEB1 and inhibits tumorigenesis in osteosarcoma.

Authors:  Huan Wang; Danmou Xing; Dong Ren; Wei Feng; Yan Chen; Zhiming Zhao; Zhihong Xiao; Zhengren Peng
Journal:  Mol Med Rep       Date:  2017-08-17       Impact factor: 3.423

10.  miR-455-5p promotes cell growth and invasion by targeting SOCO3 in non-small cell lung cancer.

Authors:  Junfeng Wang; Yanbo Wang; Dawei Sun; Jianlong Bu; Fenghai Ren; Benkun Liu; Shibo Zhang; Zigeng Xu; Sainan Pang; Shidong Xu
Journal:  Oncotarget       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.